🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Long-term Evaluation of a Nasopharyngeal Airway

RecruitingNAAges 18 Years - anyAllUniversity of Michigan
NCT07191314 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This long-term follow-up study will permit continued device use for participants of the parent study (NCT06677151). During study participation the study team will stay in contact with participants as necessary. Additionally, patients will undergo clinical follow-up as needed with their physician(s). At 12 months, participants will complete sleep questionnaires as part of this long-term follow-up period.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: -Participants who completed the parent study (HUM00179497) and wish to continue using the NPA-OSA device. Exclusion Criteria: * The participants who were non-compliant with the NPA-OSA device during their participation in the parent study.
💊

What it tests

  • nasopharyngeal airway obstructive sleep apnea (NPA-OSA) device
📍

Where

2 sites
Michigan Medicine
Ann Arbor, United States
University of Michigan
Ann Arbor, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy